FCM
VTYX

Farallon Capital Management’s Ventyx Biosciences VTYX Stock Holding History

Farallon Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,170,000
Closed -$6.91M – 173
2024
Q3 		$6.91M Hold
3,170,000
– – 0.03% 90
2024
Q2 		$7.32M Hold
3,170,000
– – 0.03% 86
2024
Q1 		$17.4M Buy
+3,170,000
New +$14.5M 0.07% 79
2022
Q4 		– Sell
-70,000
Closed -$2.44M – 253
2022
Q3 		$2.44M Sell
70,000
-860,648
-92% -$19.1M 0.01% 205
2022
Q2 		$11.4M Sell
930,648
-183,632
-16% -$2.74M 0.06% 128
2022
Q1 		$15.1M Hold
1,114,280
– – 0.07% 113
2021
Q4 		$22.1M Buy
+1,114,280
New +$21.1M 0.11% 91

Other funds holding VTYX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Farallon Capital Management's VTYX Position: Q4 2024 in Review

Farallon Capital Management sold out of Ventyx Biosciences (VTYX) in Q4 2024, closing a stake of 3,170,000 shares — an estimated $6.91M sold.

Farallon Capital Management first reported a position in VTYX in Q4 2021 and held it in 7 quarters. The position peaked at $22.1M in Q4 2021. 124 funds tracked by Wall St. Rank hold VTYX as of Q4 2024.

  • Farallon Capital Management reported no remaining Ventyx Biosciences position as of Q4 2024 after selling out during the quarter.
  • Farallon Capital Management sold 3,170,000 Ventyx Biosciences shares in Q4 2024, an estimated $6.91M.
  • Farallon Capital Management first reported a position in Ventyx Biosciences in Q4 2021 and held it in 7 quarters.
  • Farallon Capital Management's Ventyx Biosciences position peaked at $22.1M in Q4 2021.
  • 124 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2024.

Based on Farallon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.